﻿<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="systematic-review">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Explor Med</journal-id>
<journal-id journal-id-type="publisher-id">EM</journal-id>
<journal-title-group>
<journal-title>Exploration of Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2692-3106</issn>
<publisher>
<publisher-name>Open Exploration Publishing</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.37349/emed.2024.00260</article-id>
<article-id pub-id-type="manuscript">1001260</article-id>
<article-categories>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Oral health conditions and hygiene procedures in patients with Parkinson’s disease: a systematic review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6466-9825</contrib-id>
<name>
<surname>Pardo</surname>
<given-names>Alessia</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barilli</surname>
<given-names>Alice</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9761-4046</contrib-id>
<name>
<surname>Signoriello</surname>
<given-names>Annarita</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
<xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gualtieri</surname>
<given-names>Miriana</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brancato</surname>
<given-names>Gabriele</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<name>
<surname>Colapinto</surname>
<given-names>Gianluca</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lombardo</surname>
<given-names>Giorgio</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<name>
<surname>Albanese</surname>
<given-names>Massimo</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role>Writing-review &amp; editing</role>
<role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="editor">
<name>
<surname>Minervini</surname>
<given-names>Giuseppe</given-names>
</name>
<role>Academic Editor</role>
<aff>University of Campania “Luigi Vanvitelli”, Italy</aff>
</contrib>
</contrib-group>
<aff id="I1">Dentistry and Maxillo-Facial Surgery Unit, Department of Surgery, Dentistry, Paediatrics and Gynaecology (DIPSCOMI), University of Verona, 37134 Verona, Italy</aff>
<author-notes>
<corresp id="cor1">
<sup>*</sup>
<bold>Correspondence:</bold> Annarita Signoriello, Dentistry and Maxillo-Facial Surgery Unit, Department of Surgery, Dentistry, Paediatrics and Gynaecology (DIPSCOMI), University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy. <email>annarita.signoriello@univr.it</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>11</month>
<year>2024</year>
</pub-date>
<volume>5</volume>
<issue>6</issue>
<fpage>852</fpage>
<lpage>869</lpage>
<history>
<date date-type="received">
<day>09</day>
<month>08</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>10</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2024.</copyright-statement>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background:</title>
<p id="absp-1">Parkinson’s, a degenerative disease characterized by motor and non-motor symptoms, gradually leads to disability and affects ordinary gestures, including patients’ home oral hygiene. Given that poor oral conditions, with decayed teeth, halitosis, and periodontal inflammation, can represent a critical issue in patients with low compliance in oral hygiene, the aim of this review was to investigate overall oral health in patients with Parkinson’s disease (PD).</p>
</sec>
<sec>
<title>Methods:</title>
<p id="absp-2">A search on PubMed, Cochrane Library and Scopus databases was conducted to identify relevant publications: studies concerning patients with PD, their oral health conditions, and oral hygiene, also in terms of inflammation and plaque control, were included. Risk of bias analysis and qualitative analysis were performed.</p>
</sec>
<sec>
<title>Results:</title>
<p id="absp-3">Of 226 records found through the electronic search, a total of 16 studies were finally included in the systematic review. Outcomes without consistent differences between PD patients and healthy patients (control group) mainly regarded: the frequency of brushing (at least twice a day), the brushing methods (generally variable) and the frequency of dental visits (mostly regular for both groups). In patients with PD, use of interdental devices was lower, and presence of plaque was higher: due to self-reported difficulties, 15–29% of them need help for oral care, against the 1% in the healthy group. Furthermore, the longer duration and higher severity of PD seem to adversely affect overall oral health conditions.</p>
</sec>
<sec>
<title>Discussion:</title>
<p id="absp-4">Since poor oral conditions of patients with PD are associated with their disability in conducting proper home procedures, it is necessary for dental practitioners to focus on specific and personalized instructions, to be easily delivered to caregivers.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Brushing</kwd>
<kwd>degenerative disease</kwd>
<kwd>oral health</kwd>
<kwd>oral hygiene</kwd>
<kwd>Parkinson’s disease</kwd>
<kwd>plaque control</kwd>
<kwd>periodontal inflammation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p id="p-1">New technologies for diagnostics and therapy significantly extended the average lifespan of worldwide population, with remarkable improvement in quality of life. Along with the reduction of morality rates and consequent increase of life expectancy, geriatric individuals represent the fastest growing part of the population [<xref ref-type="bibr" rid="B1">1</xref>]. In 2019, approximately 7 million people over the age of 65 presented at least three chronic diseases, with almost half of them suffering from one severe pathology [<xref ref-type="bibr" rid="B2">2</xref>], such as diseases of the heart, malignant neoplasms, cerebrovascular diseases, chronic obstructive pulmonary disease, pneumonia, diabetes mellitus, Alzheimer’s disease, renal diseases, septicemia, liver diseases, and Parkinson’s disease (PD).</p>
<p id="p-2">When the risk for developing these conditions increases with longevity, a cascade effect of morbidity is established and even treatments impair other organ system, causing susceptibility to further problems [<xref ref-type="bibr" rid="B2">2</xref>]. The presence of multi-morbidity negatively affects the autonomy of elderly patients in daily life activities. While physical implications related to normal aging are generally perceived, cognitive impairment is usually slow and insidious: one of the most frequent and disabling neurodegenerative pathologies, second to Alzheimer’s disease, is PD. From 1990 to date, the overall number of people affected by PD reached 9.4 million: this estimation is expected to double [<xref ref-type="bibr" rid="B3">3</xref>] within 2040, with a prevalence of 1% for patients aged over 60 and of 4% for older age-groups [<xref ref-type="bibr" rid="B4">4</xref>].</p>
<p id="p-3">PD is characterized by a slow and progressive evolution, which causes the deterioration of dopaminergic neurons of the substantia nigra, leading to severe impairment at both motor (bradykinesia, resting tremor, rigidity, postural instability, and difficulty in walking) and non-motor (neuropsychiatric dysfunctions, such as depression, dementia, and apathy) level. As phenotypic differences make PD complex to manage [<xref ref-type="bibr" rid="B5">5</xref>], its onset and progression have an impact on daily activities, leading to scarce compliance with oral hygiene and increasing the risk for the main oral pathologies, that are caries and periodontitis. Furthermore, missing regular dental appointments results in decline of oral health and motivation [<xref ref-type="bibr" rid="B6">6</xref>], for the interference of individual changes (such as psychiatric conditions) with proper dental care.</p>
<p id="p-4">Current therapies for PD are symptomatic treatments which slow down or restore the affected dopaminergic neurons [<xref ref-type="bibr" rid="B7">7</xref>]: specific drugs, taken alone or in combination with other, are however linked to oral side effects, e.g., xerostomia, bruxism, dry throat, gingivitis, lingual edema, dysgeusia and glossitis [<xref ref-type="bibr" rid="B8">8</xref>–<xref ref-type="bibr" rid="B10">10</xref>]. On the other hand, as gradual disability affects ordinary gestures, including patients’ home care procedures, poor oral hygiene is usually associated with a greater number of decayed and extracted teeth, halitosis, and periodontal inflammation.</p>
<p id="p-5">Recent systematic reviews focus on: (i) factors associated with oral health problems [<xref ref-type="bibr" rid="B11">11</xref>], mainly caries, periodontal inflammation and prosthetic needs, and less frequently orofacial pain and dysfunction; (ii) on the role of health care providers [<xref ref-type="bibr" rid="B12">12</xref>]. As interdisciplinary approach is recommended to overcome difficulties of dental treatments, a complete overall assessment of oral conditions in PD patients can be relevant in carrying out procedures safely [<xref ref-type="bibr" rid="B13">13</xref>].</p>
<p id="p-6">In the light of these considerations, the aim of this review was to investigate overall oral conditions in patients with PD, underlying that it is fundamental to focus on their limited manual skills in daily life, providing tailored supportive oral care instructions.</p>
</sec>
<sec id="s2">
<title>Materials and methods</title>
<sec id="t2-1">
<title>Search strategy and focused question</title>
<p id="p-7">This review was performed based on the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) statement [<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>], and registered as CRD42024570627 (31/07/2024) with PROSPERO (the international prospective register of systematic reviews).</p>
<p id="p-8">The PICOS principle is described as follows:</p>
<p id="p-9">
<list list-type="simple">
<list-item>
<label>1.</label>
<p>Patients: patients with PD.</p>
</list-item>
<list-item>
<label>2.</label>
<p>Interventions: home oral hygiene procedures and oral health conditions.</p>
</list-item>
<list-item>
<label>3.</label>
<p>Comparators: healthy group (patients without PD).</p>
</list-item>
<list-item>
<label>4.</label>
<p>Outcomes: frequency of brushing, brushing methods, frequency of dental visits, use of interdental devices, use of mouthwashes, self-reported difficulties with oral hygiene, oral conditions in terms of plaque control and inflammation (plaque score, gingival score), carious lesions, factors associated with the presence of periodontal disease (duration and severity).</p>
</list-item>
<list-item>
<label>5.</label>
<p>Study design: prospective studies, Randomized clinical trials (RCTs), cross-sectional studies.</p>
</list-item>
</list>
</p>
<p id="p-10">The focused question was: “How is the overall oral health and how are oral hygiene conditions reported in literature for patients with PD?”.</p>
<p id="p-11">The Standard for Reporting Qualitative Research (SRQR) was used to conduct the qualitative review [<xref ref-type="bibr" rid="B16">16</xref>]. To identify relevant publications, a search on PubMed, Cochrane Library and Scopus databases was conducted. The search strategy is described as follows:</p>
<p id="p-12">
<list list-type="simple">
<list-item>
<label>1.</label>
<p>Pubmed: (“Parkinson Disease”[MeSH Major Topic] AND (“oral health”[All Fields] OR “oral hygiene”[All Fields] OR “periodontal diseases”[All Fields] OR “dental plaque”[All Fields]).</p>
</list-item>
<list-item>
<label>2.</label>
<p>Cochrane Library: [Parkinson Disease] explode all trees AND (“Oral Hygiene” OR “Oral Health” OR “Oral Biofilm”).</p>
</list-item>
<list-item>
<label>3.</label>
<p>Scopus: TITLE-ABS-KEY (“Parkinson Disease” AND “oral health”) OR TITLE-ABS-KEY (“Parkinson Disease” AND “oral hygiene”) OR TITLE-ABS-KEY (“Parkinson Disease” AND “periodontal diseases”) OR TITLE-ABS-KEY (“Parkinson Disease” AND “dental plaque”).</p>
</list-item>
</list>
</p>
</sec>
<sec id="t2-2">
<title>Inclusion criteria, selection of studies and bias assessment</title>
<p id="p-13">Studies included were in accordance with the following criteria:</p>
<p id="p-14">
<list list-type="simple">
<list-item>
<label>1.</label>
<p>Patients affected by PD (the specific systemic disease considered).</p>
</list-item>
<list-item>
<label>2.</label>
<p>Factors related to patients’ oral health conditions and home oral hygiene procedures:</p>
<p>
<list list-type="simple">
<list-item>
<label>a)</label>
<p>Frequency of brushing and brushing methods.</p>
</list-item>
<list-item>
<label>b)</label>
<p>Frequency of dental visits.</p>
</list-item>
<list-item>
<label>c)</label>
<p>Use of interdental devices.</p>
</list-item>
<list-item>
<label>d)</label>
<p>Use of mouthwashes.</p>
</list-item>
<list-item>
<label>e)</label>
<p>Self-reported difficulties with oral hygiene.</p>
</list-item>
<list-item>
<label>f)</label>
<p>Plaque control and inflammation (plaque score and gingival score).</p>
</list-item>
<list-item>
<label>g)</label>
<p>Carious lesions.</p>
</list-item>
<list-item>
<label>h)</label>
<p>Factors associated with the presence of periodontal disease (duration and severity).</p>
</list-item>
</list>
</p>
</list-item>
<list-item>
<label>3.</label>
<p>Articles written in English.</p>
</list-item>
</list>
</p>
<p id="p-15">Not available full texts, letters, editorials, interviews, systematic literature reviews and articles published before 2013 were excluded (a temporal limitation of the last 10 years was considered as suitable for a concrete assessment, based on current and updated knowledge, regarding the topic of the review).</p>
<p id="p-16">The records selection was conducted by two independent reviewers, removing duplicates as the first step, analyzing titles and abstracts of the remaining records, and finally selecting relevant full texts for the abovementioned inclusion criteria. In case of disagreement between the two reviewers, a third party intervened in the decision-making process.</p>
<p id="p-17">The methodological quality of the selected full text articles was assessed using:</p>
<p id="p-18">
<list list-type="simple">
<list-item>
<label>1.</label>
<p>The Cochrane Risk Bias Tool for RCTs [<xref ref-type="bibr" rid="B17">17</xref>], with a fixed set of domains of bias, regarding different aspects of trial design, conduct, and reporting; bias was declared for individual elements from five domains of bias (selection, performance, attrition, reporting, and other).</p>
</list-item>
<list-item>
<label>2.</label>
<p>The AXIS-Tool for cross-sectional studies was instead used [<xref ref-type="bibr" rid="B18">18</xref>], with a score varying from 14 points to 18 points, based on the result of 20 questions, which were as follows:</p>
</list-item>
</list>
</p>
<p id="p-19">Q1 = where the aims/objectives of the study clear?</p>
<p id="p-20">Q2 = was the study design appropriate for the stated aim(s)?</p>
<p id="p-21">Q3 = was the sample size justified?</p>
<p id="p-22">Q4 = was the target/reference population clearly defined (is it clear who the research was about?)?</p>
<p id="p-23">Q5 = was the sample frame taken from an appropriate population base so that it closely represented the target/reference population under investigation?</p>
<p id="p-24">Q6 = was the selection process likely to select subjects/participants that were representative of the target/reference population under investigation?</p>
<p id="p-25">Q7 = were measures undertaken to address and categorise non-responders?</p>
<p id="p-26">Q8 = were the risk factor and outcome variables measured appropriate to the aims of the study?</p>
<p id="p-27">Q9 = were the risk factor and outcome variables measured correctly using instruments/measurements that had been trilled, piloted, or published previously?</p>
<p id="p-28">Q10 = is it clear what was used to determine statistical significance and/or precision estimates (e.g., <italic>P</italic>-values, confidence intervals)?</p>
<p id="p-29">Q11 = were the methods (including statistical methods) sufficiently described to enable them to be repeated?</p>
<p id="p-30">Q12 = were the basic data adequately described?</p>
<p id="p-31">Q13 = does the response rate raises concerns about non-responders bias?</p>
<p id="p-32">Q14 = if appropriate, was information about non-responders described?</p>
<p id="p-33">Q15 = were the results internally consistent?</p>
<p id="p-34">Q16 = were the results presented for all the analyses described in the methods?</p>
<p id="p-35">Q17 = were the author’s discussions and conclusions justified by the results?</p>
<p id="p-36">Q18 = were the limitations of the study discussed?</p>
<p id="p-37">Q19 = were there any funding sources or conflicts of interest that may affect the authors’ interpretation of the results?</p>
<p id="p-38">Q20 = was ethical approval or consent of participants attained?</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<p id="p-39">A number of 226 articles were obtained from the initial search, 84 in PubMed, 69 in Cochrane Library and 73 in Scopus. After removing duplicates, 200 were evaluated. After following the study selection procedure, 16 were included (see <xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<fig id="fig1" position="float">
<label>Figure 1</label>
<caption>
<p id="fig1-p-1">Research flow diagram according to PRISMA statement. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta Analyses</p>
<p id="fig1-p-2">
<italic>Note.</italic> Adapted from “The PRISMA 2020 statement: an updated guideline for reporting systematic reviews” by Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. BMJ. 2021;372:n71 (<uri xlink:href="https://doi.org/10.1136/bmj.n71">https://doi.org/10.1136/bmj.n71</uri>). CC BY.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="em-05-1001260-g001.tif" />
</fig>
<sec id="t3-1">
<title>Overall characteristics of participants of the selected studies</title>
<p id="p-40">Overall characteristics of participants of selected studies are presented in <xref ref-type="table" rid="t1">Table 1</xref>. Concerning the evaluation of disease stage and severity, two methods were used in the studies examined:</p>
<p id="p-41">
<list list-type="simple">
<list-item>
<label>1.</label>
<p>The Movement Disorders Society-Unified Parkinson Disease Rating scale-part III (MDS-UPDRS-III) [<xref ref-type="bibr" rid="B19">19</xref>]: it is a clinical rating scale structured in four parts. The first part concerns the non-motor experiences of everyday life, the second considers motor experiences, the third section evaluates motor skills, and the last section evaluates complications.</p>
</list-item>
<list-item>
<label>2.</label>
<p>The Hoehn &amp; Yahr Scale [<xref ref-type="bibr" rid="B20">20</xref>]: this method describes the progression of the disease through the various stages and allows the severity of the case to be measured. The evaluation takes place on the basis of in-depth examination and anamnesis provided by the patients, including 5 stages: in the first stage the patient has unilateral symptoms; in the second stage the patient has bilateral involvement without compromise in balance; in the third stage bilateral disease is mild to moderate with postural instability; stage 4 indicates severe disability and the patient is still able to walk or stand unaided; in stage 5 the patient is confined to a wheelchair or bed if unassisted.</p>
</list-item>
</list>
</p>
<table-wrap id="t1">
<label>Table 1</label>
<caption>
<p id="t1-p-1">Overall characteristics of participants of the selected studies</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Design</bold>
</th>
<th>
<bold>Country</bold>
</th>
<th>
<bold>Number of PD patients</bold>
</th>
<th>
<bold>Number of healthy patients (control)</bold>
</th>
<th>
<bold>Age of PD patients (years)</bold>
</th>
<th>
<bold>Age of healthy patients (years)</bold>
</th>
<th>
<bold>Disease stage (Hoehn &amp; Yahr) [<xref ref-type="bibr" rid="B20">20</xref>]</bold>
</th>
<th>
<bold>Disease severity (MDS UPDRS-III) [<xref ref-type="bibr" rid="B19">19</xref>]</bold>
</th>
<th>
<bold>Disease duration (years)</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Baram et al. [<xref ref-type="bibr" rid="B21">21</xref>], 2020</td>
<td>RCT</td>
<td>Denmark</td>
<td>29</td>
<td>-</td>
<td>32–72</td>
<td>-</td>
<td>2.9 ± 0.4</td>
<td>20.6 ± 4.9</td>
<td>11.7 ± 5.0</td>
</tr>
<tr>
<td>Baram et al. [<xref ref-type="bibr" rid="B22">22</xref>], 2023</td>
<td>CS</td>
<td>Denmark</td>
<td>6,874</td>
<td>34,285</td>
<td>71 (58–82)</td>
<td>71 (58–82)</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>CS</td>
<td>Germany</td>
<td>100</td>
<td>-</td>
<td>71 ± 8.7</td>
<td>-</td>
<td>-</td>
<td>17.5 ± 8.6</td>
<td>-</td>
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B24">24</xref>], 2017</td>
<td>CS</td>
<td>Germany</td>
<td>26</td>
<td>26</td>
<td>69 ± 9.0</td>
<td>69 ± 9.0</td>
<td>-</td>
<td>13.0 ± 9.0</td>
<td>9.0 ± 4.0</td>
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B25">25</xref>], 2017</td>
<td>CS</td>
<td>Germany</td>
<td>30</td>
<td>30</td>
<td>69.3 ± 8.0</td>
<td>69.3 ± 7.9</td>
<td>-</td>
<td>12.0 ± 8.8</td>
<td>-</td>
</tr>
<tr>
<td>Fleury et al. [<xref ref-type="bibr" rid="B26">26</xref>], 2021</td>
<td>CS</td>
<td>Switzerland</td>
<td>20</td>
<td>20</td>
<td>62.8</td>
<td>64.3</td>
<td>2</td>
<td>15</td>
<td>4.7</td>
</tr>
<tr>
<td>García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>CS</td>
<td>Spain</td>
<td>104</td>
<td>106</td>
<td>66.2 ± 9.2</td>
<td>59.2 ± 14.1</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>García-de-la-Fuente et al. [<xref ref-type="bibr" rid="B28">28</xref>], 2023</td>
<td>CS</td>
<td>Spain</td>
<td>104</td>
<td>106</td>
<td>66.2 ± 9.2</td>
<td>66.2 ± 9.2</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>John et al. [<xref ref-type="bibr" rid="B29">29</xref>], 2021</td>
<td>CS</td>
<td>India</td>
<td>32</td>
<td>42</td>
<td>58.4 ± 10.6</td>
<td>66.2 ± 9.2</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>], 2020</td>
<td>CS</td>
<td>Portugal</td>
<td>28</td>
<td>-</td>
<td>72.3 ± 8.1</td>
<td>-</td>
<td>2.7</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>Pradeep et al. [<xref ref-type="bibr" rid="B31">31</xref>], 2015</td>
<td>CS</td>
<td>India</td>
<td>45</td>
<td>46</td>
<td>54.5 ± 9.1</td>
<td>63.9 ± 13.1</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>Ribeiro et al. [<xref ref-type="bibr" rid="B32">32</xref>], 2016</td>
<td>CS</td>
<td>Brazil</td>
<td>17</td>
<td>20</td>
<td>69.41 ± 4.65</td>
<td>72.00 ± 5.69</td>
<td>-</td>
<td>-</td>
<td>6.76 ± 3.80</td>
</tr>
<tr>
<td>Ribeiro et al. [<xref ref-type="bibr" rid="B33">33</xref>], 2017</td>
<td>CS</td>
<td>Brazil</td>
<td>17</td>
<td>17</td>
<td>69.4 ± 4.7</td>
<td>70.7 ± 4.7</td>
<td>-</td>
<td>-</td>
<td>6.76 ± 3.80</td>
</tr>
<tr>
<td>Rozas et al. [<xref ref-type="bibr" rid="B34">34</xref>], 2021</td>
<td>CS</td>
<td>USA</td>
<td>30</td>
<td>30</td>
<td>69.2 ± 9.4</td>
<td>69.1 ± 8.4</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>CS</td>
<td>Netherlands</td>
<td>74</td>
<td>74</td>
<td>70.2 ± 8.8</td>
<td>67.9 ± 10.1</td>
<td>2.4</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>Verhoeff et al. [<xref ref-type="bibr" rid="B36">36</xref>], 2022</td>
<td>CS</td>
<td>Netherlands</td>
<td>341</td>
<td>411</td>
<td>65.5 ± 8.4</td>
<td>62.6 ± 5.3</td>
<td>-</td>
<td>11.5 ± 7.5</td>
<td>7.0 ± 5.5</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t1-fn-1">-: unknown; CS: cross sectional; RCT: randomized clinical trial; MDS-UPDRS-III: Movement Disorders Society-Unified Parkinson Disease Rating scale-part III; PD: Parkinson’s disease. Age, disease stage/severity/duration are expressed in years as mean ± SD (standard deviation)</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="t3-2">
<title>Quality assessment of the selected studies</title>
<p id="p-42">The quality assessment for cross-sectional studies conducted with AXIS TOOL evidenced a moderate/good quality for articles analyzed (see <xref ref-type="table" rid="t2">Table 2</xref>).</p>
<table-wrap id="t2">
<label>Table 2</label>
<caption>
<p id="t2-p-1">The quality assessment for cross-sectional studies conducted with AXIS TOOL (item is reverse scored)</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Q1</bold>
</th>
<th>
<bold>Q2</bold>
</th>
<th>
<bold>Q3</bold>
</th>
<th>
<bold>Q4</bold>
</th>
<th>
<bold>Q5</bold>
</th>
<th>
<bold>Q6</bold>
</th>
<th>
<bold>Q7</bold>
</th>
<th>
<bold>Q8</bold>
</th>
<th>
<bold>Q9</bold>
</th>
<th>
<bold>Q10</bold>
</th>
<th>
<bold>Q11</bold>
</th>
<th>
<bold>Q12</bold>
</th>
<th>
<bold>Q13</bold>
</th>
<th>
<bold>Q14</bold>
</th>
<th>
<bold>Q15</bold>
</th>
<th>
<bold>Q16</bold>
</th>
<th>
<bold>Q17</bold>
</th>
<th>
<bold>Q18</bold>
</th>
<th>
<bold>Q19</bold>
</th>
<th>
<bold>Q20</bold>
</th>
<th>
<bold>Axis</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Baram et al. [<xref ref-type="bibr" rid="B22">22</xref>], 2023</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>17</td>
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>17</td>
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B24">24</xref>], 2017</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>17</td>
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B25">25</xref>], 2017</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>17</td>
</tr>
<tr>
<td>Fleury et al. [<xref ref-type="bibr" rid="B26">26</xref>], 2021</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N</td>
<td>Y</td>
<td>17</td>
</tr>
<tr>
<td>García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N</td>
<td>N</td>
<td>Y</td>
<td>14</td>
</tr>
<tr>
<td>García-de-la-Fuente et al. [<xref ref-type="bibr" rid="B28">28</xref>], 2023</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N</td>
<td>N</td>
<td>Y</td>
<td>14</td>
</tr>
<tr>
<td>John et al. [<xref ref-type="bibr" rid="B29">29</xref>], 2021</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>Y</td>
<td>17</td>
</tr>
<tr>
<td>Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>], 2020</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>Y</td>
<td>17</td>
</tr>
<tr>
<td>Pradeep et al. [<xref ref-type="bibr" rid="B31">31</xref>], 2015</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>?</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N</td>
<td>Y</td>
<td>15</td>
</tr>
<tr>
<td>Ribeiro et al. [<xref ref-type="bibr" rid="B32">32</xref>], 2016</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>-</td>
<td>Y</td>
<td>15</td>
</tr>
<tr>
<td>Ribeiro et al. [<xref ref-type="bibr" rid="B33">33</xref>], 2017</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>16</td>
</tr>
<tr>
<td>Rozas et al. [<xref ref-type="bibr" rid="B34">34</xref>], 2021</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>Y</td>
<td>17</td>
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>-</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>N/A</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>Y</td>
<td>18</td>
</tr>
<tr>
<td>Verhoeff et al. [<xref ref-type="bibr" rid="B36">36</xref>], 2022</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>Y</td>
<td>N</td>
<td>Y</td>
<td>18</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t2-fn-1">-: unclear; Q: question; Y: yes; N: no; N/A: not applicable</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p id="p-43">The quality of the RTC study assessed with the Cochrane Risk of Bias Tool reported an unclear risk of bias (see <xref ref-type="table" rid="t3">Table 3</xref>).</p>
<table-wrap id="t3">
<label>Table 3</label>
<caption>
<p id="t3-p-1">Instrument for methodological quality for RCT studies using Cochrane Risk of Bias Tool</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Paper</bold>
</th>
<th>
<bold>Selection bias</bold>
</th>
<th>
<bold>Performance bias</bold>
</th>
<th>
<bold>Detection bias</bold>
</th>
<th>
<bold>Attrition bias</bold>
</th>
<th>
<bold>Reporting bias</bold>
</th>
<th>
<bold>Other bias</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Baram et al. [<xref ref-type="bibr" rid="B21">21</xref>], 2020</td>
<td>-</td>
<td>+</td>
<td>+</td>
<td>-</td>
<td>-</td>
<td>+</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t3-fn-1">+: bias present; -: bias not present; RCT: randomized clinical trial</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="t3-3">
<title>Home oral hygiene habits: frequency and methods of brushing</title>
<p id="p-44">Approximately 60% of PD patients (see <xref ref-type="table" rid="t4">Table 4</xref>) brush their teeth at least twice a day [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B36">36</xref>]. In this proposal, García-de-la-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>], analysed 104 PD subjects and 106 control cases, with non-homogeneous age: 5.8% of patients in the first group (vs. 1.9% in the control) declared to not perform oral hygiene manoeuvres at home. Rozas et al. [<xref ref-type="bibr" rid="B34">34</xref>] presented two groups homogeneous for age, gender, and number of participants: 73% of healthy patients mechanically removed their plaque, while only 60% of PD patients used to brush twice daily.</p>
<table-wrap id="t4">
<label>Table 4</label>
<caption>
<p id="t4-p-1">Home oral hygiene habits: frequency and methods of brushing</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Home oral hygiene habits</bold>
</th>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Parkinson group</bold>
</th>
<th>
<bold>Healthy group</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="14">Brushing frequency</td>
<td rowspan="3">Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>21% 1 × day</td>
<td>N/A</td>
</tr>
<tr>
<td>64% 2 × day</td>
<td>N/A</td>
</tr>
<tr>
<td>15% 3 × day</td>
<td>N/A</td>
</tr>
<tr>
<td>Fleury et al. [<xref ref-type="bibr" rid="B26">26</xref>], 2021</td>
<td>100% ≥ 1 × day</td>
<td>100% ≥ 1 × day</td>
</tr>
<tr>
<td rowspan="5">García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>2 × day</td>
<td>2 × day</td>
</tr>
<tr>
<td>5.8% none</td>
<td>1.9% none</td>
</tr>
<tr>
<td>22.1% 1 × day</td>
<td>17% 1 × day</td>
</tr>
<tr>
<td>26% 2 × day</td>
<td>31.1% 2 × day</td>
</tr>
<tr>
<td>46.20% &gt; 2 × day</td>
<td>50% &gt; 2 × day</td>
</tr>
<tr>
<td rowspan="2">Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>], 2020</td>
<td>32.1% 1 × day</td>
<td>N/A</td>
</tr>
<tr>
<td>67.9% ≥ 2 × day</td>
<td>N/A</td>
</tr>
<tr>
<td>Pradeep et al. [<xref ref-type="bibr" rid="B31">31</xref>], 2015</td>
<td>76% &gt; 1 × day</td>
<td>76% &gt; 1 × day</td>
</tr>
<tr>
<td>Rozas et al. [<xref ref-type="bibr" rid="B34">34</xref>], 2021</td>
<td>60% ≥ 2 × day</td>
<td>73% ≥ 2 × day</td>
</tr>
<tr>
<td>Verhoeff et al. [<xref ref-type="bibr" rid="B36">36</xref>], 2022</td>
<td>72.7% ≥ 2 × day</td>
<td>N/A</td>
</tr>
<tr>
<td rowspan="5">Brushing methods</td>
<td>Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>43% electric toothbrush</td>
<td>N/A</td>
</tr>
<tr>
<td>García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>4% electric toothbrush</td>
<td>7.6% electric toothbrush</td>
</tr>
<tr>
<td>Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>], 2020</td>
<td>25% electric toothbrush</td>
<td>N/A</td>
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>48.6% electric toothbrush</td>
<td>40.5% electric toothbrush</td>
</tr>
<tr>
<td>Verhoeff et al. [<xref ref-type="bibr" rid="B36">36</xref>], 2022</td>
<td>78% electric toothbrush</td>
<td>N/A</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t4-fn-1">N/A: not applicable. Frequency of brushing is reported in percentage (%) of participants for each group brushing teeth 1, 2 or 3 times × day, or only in number of times × day for each group; type of device is reported in percentage (%) of participants for each group</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p id="p-45">Regarding brushing methods (see again <xref ref-type="table" rid="t4">Table 4</xref>), only two studies [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B35">35</xref>] indicate a good percentage (40–50%) of electric toothbrush users among PD patients. Verhoeff et al. [<xref ref-type="bibr" rid="B36">36</xref>] found 78% of users among 341 PD patients. van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>] analyzed 74 PD patients (at a mild disease stage) and 74 healthy patients, finding that electric toothbrush was respectively used in 48.6% and 40.5% of cases.</p>
</sec>
<sec id="t3-4">
<title>Home oral hygiene habits: interdental devices and use of mouthwash</title>
<p id="p-46">García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>] highlighted (see <xref ref-type="table" rid="t5">Table 5</xref>) a lower frequency of interdental cleaning, as well as a lower use of brush and dental floss, in PD patients compared to healthy subjects. Verhoeff et al. [<xref ref-type="bibr" rid="B36">36</xref>] described use of dental floss, toothpicks, metal brush and rubber brush. Regarding the use of mouthwash (see again <xref ref-type="table" rid="t5">Table 5</xref>), no substantial differences between groups were reported [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B22">22</xref>].</p>
<table-wrap id="t5">
<label>Table 5</label>
<caption>
<p id="t5-p-1">Home oral hygiene habits: interdental devices and use of mouthwash</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Home oral hygiene habits</bold>
</th>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Parkinson group</bold>
</th>
<th>
<bold>Healthy group</bold>
</th>
<th>
<bold>Type of device</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="14">Interdental devices</td>
<td>Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>No</td>
<td>N/A</td>
<td />
</tr>
<tr>
<td rowspan="6">García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>33.7%</td>
<td>49.1%</td>
<td>Interdental cleaning</td>
</tr>
<tr>
<td>19.2%</td>
<td>29.2%</td>
<td>Interdental brush</td>
</tr>
<tr>
<td>10.6%</td>
<td>16%</td>
<td>Dental floss</td>
</tr>
<tr>
<td>1.9%</td>
<td>2.8%</td>
<td>Water flosser</td>
</tr>
<tr>
<td>10.6%</td>
<td>16.2%</td>
<td>Mouthwash alcol-free</td>
</tr>
<tr>
<td>51.9%</td>
<td>51.9%</td>
<td>Mouthwash</td>
</tr>
<tr>
<td>Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>], 2020</td>
<td>39%</td>
<td>N/A</td>
<td />
</tr>
<tr>
<td>Pradeep et al. [<xref ref-type="bibr" rid="B31">31</xref>], 2015</td>
<td>13%</td>
<td>19.5%</td>
<td>Dental floss</td>
</tr>
<tr>
<td>Rozas et al. [<xref ref-type="bibr" rid="B34">34</xref>], 2021</td>
<td>47%</td>
<td>50%</td>
<td>Dental floss</td>
</tr>
<tr>
<td rowspan="4">Verhoeff et al. [<xref ref-type="bibr" rid="B36">36</xref>], 2022</td>
<td>39% ≥ 1 times/die</td>
<td rowspan="4">N/A</td>
<td rowspan="4" />
</tr>
<tr>
<td>50% toothpick</td>
</tr>
<tr>
<td>34.8% rubber pipe cleaner</td>
</tr>
<tr>
<td>43.2% metal pipe cleaner</td>
</tr>
<tr>
<td rowspan="4">Use of mouthwash</td>
<td rowspan="2">García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>10.6%</td>
<td>16.2%</td>
<td>Mouthwash alcol-free</td>
</tr>
<tr>
<td>51.9%</td>
<td>51.9%</td>
<td />
</tr>
<tr>
<td>Pradeep et al. [<xref ref-type="bibr" rid="B31">31</xref>], 2015</td>
<td>35.60%</td>
<td>39.10%</td>
<td />
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>38%</td>
<td>N/A</td>
<td />
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t5-fn-1">N/A: not applicable. Use of interdental devices or mouthwah is reported in percentage (%) of participants for each group, with eventual specification of device type</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="t3-5">
<title>Home oral hygiene habits: self-reported difficulties and subjective oral hygiene measures awareness</title>
<p id="p-47">Self-reported difficulties (see <xref ref-type="table" rid="t6">Table 6</xref>) were assessed through the delivery of questionnaires. According to Barbe et al. [<xref ref-type="bibr" rid="B25">25</xref>] and van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>] 29% and 15% of PD patients respectively required help and assistance.</p>
<table-wrap id="t6">
<label>Table 6</label>
<caption>
<p id="t6-p-1">Home oral hygiene habits: self-reported difficulties and subjective oral hygiene measures awareness</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Home oral hygiene habits</bold>
</th>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Parkinson group</bold>
</th>
<th>
<bold>Healthy group</bold>
</th>
<th>
<bold>Self-report</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">Self-reported difficulties</td>
<td>Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>29% need help</td>
<td>N/A</td>
<td />
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>15% need help</td>
<td>1% need help</td>
<td />
</tr>
<tr>
<td rowspan="3">Subjective oral hygiene</td>
<td rowspan="3">García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>31.7%</td>
<td>45.3%</td>
<td>Good</td>
</tr>
<tr>
<td>48.1%</td>
<td>40.6%</td>
<td>Moderate</td>
</tr>
<tr>
<td>20.2%</td>
<td>14.2%</td>
<td>Bad</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t6-fn-1">N/A: not applicable. Variable is reported in percentage (%) of participants for each group, with eventual specification of degree</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p id="p-48">Subjective oral hygiene measures awareness of the patient’s level of oral hygiene (see again <xref ref-type="table" rid="t6">Table 6</xref>) was determined by García-de-la-Fuente et al. [<xref ref-type="bibr" rid="B28">28</xref>], administering a questionnaire on home oral hygiene habits: the degree of subjective hygiene was categorized into three options: “insufficient”, “sufficient”, “good”.</p>
</sec>
<sec id="t3-6">
<title>Presence of plaque and gingival inflammation</title>
<p id="p-49">Most of the articles (see <xref ref-type="table" rid="t7">Table 7</xref>) revealed a greater presence of biofilm in the test group, with significant data in plaque indices [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>–<xref ref-type="bibr" rid="B18">18</xref>]. García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>] reported the full mouth plaque index (FMPI) as below 25% in 2.9% of PD patients, vs. 12.3% of healthy ones; as above 50% in 76.9% of PD patients, vs. 60.4% of healthy ones. Ribeiro et al. [<xref ref-type="bibr" rid="B32">32</xref>] considered the Visible Plaque Index in 17 PD and 20 healthy patients with a homogeneous average age, reporting values of 91.8 ± 16.9 in PD and 64.10 ± 48.9 in healthy patients, respectively. Rozas et al. [<xref ref-type="bibr" rid="B34">34</xref>] found differences in the Oral Hygiene Index-Simplified plaque index between the two groups before brushing, while a notable decrease, in both, after brushing. van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>] declared 60% plaque deposits in PD patients, compared to 31% in healthy patients.</p>
<table-wrap id="t7">
<label>Table 7</label>
<caption>
<p id="t7-p-1">Home oral hygiene habits: presence of plaque and gingival inflammation</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Home oral hygiene habits</bold>
</th>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Parkinson group</bold>
</th>
<th>
<bold>Healthy group</bold>
</th>
<th>
<bold>Additional information</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="13">Presence of plaque</td>
<td>Baram et al. [<xref ref-type="bibr" rid="B21">21</xref>], 2020</td>
<td>1.1 ± 0.6 OH-DSI</td>
<td>N/A</td>
<td />
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>1.7 (0.9%) PI</td>
<td>1.0 (0.8%) PI</td>
<td />
</tr>
<tr>
<td>Fleury et al. [<xref ref-type="bibr" rid="B26">26</xref>], 2021</td>
<td>1.29 PI</td>
<td>0.97 PI</td>
<td />
</tr>
<tr>
<td rowspan="4">García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>72.2 ± 22.2 PI</td>
<td>62 ± 25.9 PI</td>
<td />
</tr>
<tr>
<td>2.9%</td>
<td>12.30%</td>
<td>FMPI &lt; 25%</td>
</tr>
<tr>
<td>17.3%</td>
<td>24.5%</td>
<td>FMPI 25–50%</td>
</tr>
<tr>
<td>76.90%</td>
<td>60.4%</td>
<td>FMPI &gt; 50%</td>
</tr>
<tr>
<td>John et al. [<xref ref-type="bibr" rid="B29">29</xref>], 2021</td>
<td>3.1 ± 0.81 OHI</td>
<td>1.3 ± 0.4 OHI</td>
<td />
</tr>
<tr>
<td>Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>], 2020</td>
<td>37.0 ± 29.4 PI</td>
<td>N/A</td>
<td />
</tr>
<tr>
<td>Ribeiro et al. [<xref ref-type="bibr" rid="B32">32</xref>], 2016</td>
<td>91.8 ± 16.9 PI</td>
<td>64.1 ± 48.9 PI</td>
<td />
</tr>
<tr>
<td rowspan="2">Rozas et al. [<xref ref-type="bibr" rid="B34">34</xref>], 2021</td>
<td>1.6 ± 0.13 OHI-S</td>
<td>1.0 ± 0.16 OHI-S</td>
<td>Before brushing</td>
</tr>
<tr>
<td>0.54 ± 0.08 OHI-S</td>
<td>0.39 ± 0.1 OHI-S</td>
<td>After brushing</td>
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>60%</td>
<td>31%</td>
<td />
</tr>
<tr>
<td rowspan="3">Presence of bleeding</td>
<td>Fleury et al. [<xref ref-type="bibr" rid="B26">26</xref>], 2021</td>
<td>57.90%</td>
<td>51.50%</td>
<td />
</tr>
<tr>
<td>Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>], 2020</td>
<td>19.3 ± 21.2 BoP</td>
<td>N/A</td>
<td />
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>20%</td>
<td>18.50%</td>
<td />
</tr>
<tr>
<td rowspan="3">Presence of gingivitis</td>
<td>Barbe et al. [<xref ref-type="bibr" rid="B25">25</xref>], 2017</td>
<td>1.8 ± 0.8</td>
<td>N/A</td>
<td />
</tr>
<tr>
<td>Barbe et al. [<xref ref-type="bibr" rid="B24">24</xref>], 2017</td>
<td>1.9 ± 0.8 GI</td>
<td>0.8 ± 1.1 GI</td>
<td />
</tr>
<tr>
<td>John et al. [<xref ref-type="bibr" rid="B29">29</xref>], 2021</td>
<td>1.5 ± 0.4 MGI</td>
<td>0.7 ± 0.2</td>
<td />
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t7-fn-1">N/A: not applicable; PI: plaque index; OHI: oral hygiene index; OHI-S: oral hygiene index semplified; OH-DSI: oral hygiene-debris semplified index; FMPI: full mouth plaque index; BoP: bleeding on probing; GI: gingivitis index; MGI: modified gingival index. Presence of plaque or bleeding is reported in percentage (%) of participants for each group presenting the condition, if not otherwise specified through the use of specific parameters, expressed in % or mean ± SD (standard deviation), depending on the study</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p id="p-50">Gingival inflammation (see again <xref ref-type="table" rid="t7">Table 7</xref>) was evaluated with the presence of bleeding on probing (BoP) [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B30">30</xref>] and the presence of gingivitis. van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>] considered the self-assessment performed by patients, identifying gum bleeding during brushing: the test group revealed 20% cases in PD patients, compared to 18.5% of the control group. Regarding the presence of gingivitis, studies [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B29">29</xref>] generally reported higher values in PD patients compared to healthy patients: Barbe et al. [<xref ref-type="bibr" rid="B25">25</xref>] examined the gingivitis index (GI), which analyses the presence of bleeding, changes in colour and consistency of the mucosa, while John et al. [<xref ref-type="bibr" rid="B29">29</xref>] examined the modified gingival index (MGI).</p>
</sec>
<sec id="t3-7">
<title>Frequency of dental visits</title>
<p id="p-51">As regards the frequency of dental visits (see <xref ref-type="table" rid="t8">Table 8</xref>), the two groups analysed appeared mostly regular [<xref ref-type="bibr" rid="B22">22</xref>], for and approximate frequency of ≥ 2 times a year [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B36">36</xref>]. Some studies [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B35">35</xref>] found that periodic checks were performed with a follow-up of less than 6 months.</p>
<table-wrap id="t8">
<label>Table 8</label>
<caption>
<p id="t8-p-1">Frequency of dental visits</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Parkinson group</bold>
</th>
<th>
<bold>Healthy group</bold>
</th>
<th>
<bold>Frequency</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>53.10%</td>
<td />
<td>2 times/year</td>
</tr>
<tr>
<td>34.70%</td>
<td />
<td>once/year</td>
</tr>
<tr>
<td rowspan="7">Baram et al. [<xref ref-type="bibr" rid="B22">22</xref>], 2023</td>
<td>21.40%</td>
<td>23.60%</td>
<td>No dental care</td>
</tr>
<tr>
<td>21%</td>
<td>16.90%</td>
<td>Irregular</td>
</tr>
<tr>
<td>57.50%</td>
<td>59.50%</td>
<td>Regular</td>
</tr>
<tr>
<td>5.40%</td>
<td>2.70%</td>
<td>0 times/year</td>
</tr>
<tr>
<td>17.60%</td>
<td>23%</td>
<td>1–5 times/year</td>
</tr>
<tr>
<td>40.50%</td>
<td>48.60%</td>
<td>6–10 times/year</td>
</tr>
<tr>
<td>36.50%</td>
<td>25.70%</td>
<td>&gt; 11 times/year</td>
</tr>
<tr>
<td>Fleury et al. [<xref ref-type="bibr" rid="B26">26</xref>], 2021</td>
<td>100%</td>
<td>100%</td>
<td>≥ once/year</td>
</tr>
<tr>
<td rowspan="3">Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>], 2020</td>
<td>64.30%</td>
<td />
<td>&lt; 6 months</td>
</tr>
<tr>
<td>14.30%</td>
<td />
<td>6–12 months</td>
</tr>
<tr>
<td>21.40%</td>
<td />
<td>&gt; 12 months</td>
</tr>
<tr>
<td>Pradeep et al. [<xref ref-type="bibr" rid="B31">31</xref>], 2015</td>
<td>28.8%</td>
<td>32.60%</td>
<td>&gt; 1 once/year</td>
</tr>
<tr>
<td>Rozas et al. [<xref ref-type="bibr" rid="B34">34</xref>], 2021</td>
<td>57%</td>
<td>50%</td>
<td>≥ 2 times/die</td>
</tr>
<tr>
<td rowspan="6">van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>70.30%</td>
<td>66.20%</td>
<td>Last visit less than 6 months</td>
</tr>
<tr>
<td>20.30%</td>
<td>29.80%</td>
<td>Between 6 months and 2 years</td>
</tr>
<tr>
<td>5.40%</td>
<td>2.70%</td>
<td>0 times/year</td>
</tr>
<tr>
<td>17.60%</td>
<td>23%</td>
<td>1–5 times/year</td>
</tr>
<tr>
<td>40.50%</td>
<td>48.60%</td>
<td>6–10 times/year</td>
</tr>
<tr>
<td>36.50%</td>
<td>25.70%</td>
<td>&gt; 11 times/year</td>
</tr>
<tr>
<td>Verhoeff et al. [<xref ref-type="bibr" rid="B36">36</xref>], 2022</td>
<td>73%</td>
<td />
<td>≥ 2 times/year</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t8-fn-1">Frequency of dental visits is reported in percentage (%) of participants for each group presenting the frequency specified in the third column</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="t3-8">
<title>Prevalence of caries</title>
<p id="p-52">Only one article (see <xref ref-type="table" rid="t9">Table 9</xref>) showed a higher prevalence of caries in PD patients, using the epidemiological tool Decay Teeth, reporting 74 decayed surfaces compared to 12 in the healthy group [<xref ref-type="bibr" rid="B35">35</xref>]. The other studies analyzed did not give results with significant differences [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B32">32</xref>].</p>
<table-wrap id="t9">
<label>Table 9</label>
<caption>
<p id="t9-p-1">Prevalence of caries</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Parkinson group</bold>
</th>
<th>
<bold>Healthy group</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fleury et al. [<xref ref-type="bibr" rid="B26">26</xref>], 2021</td>
<td>10%</td>
<td>10%</td>
</tr>
<tr>
<td rowspan="2">García-De-La-Fuente et al. [<xref ref-type="bibr" rid="B27">27</xref>], 2022</td>
<td>18.8 ± 7.3 DMFT</td>
<td>17.8 ± 7.7 DMFT</td>
</tr>
<tr>
<td>2.3 ± 3.0 DT</td>
<td>1.7 ± 2.3 DT</td>
</tr>
<tr>
<td>John et al. [<xref ref-type="bibr" rid="B29">29</xref>], 2021</td>
<td>7.72 ± 4.45 DMFT</td>
<td>4.57 ± 3.58 DMFT</td>
</tr>
<tr>
<td>Ribeiro et al. [<xref ref-type="bibr" rid="B32">32</xref>], 2016</td>
<td>24.8 ± 3.8 DMFT</td>
<td>26.9 ± 2.2 DMFT</td>
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>74 DT</td>
<td>12 DT</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t9-fn-1">DT: decayed teeth; DMFT: decayed, missing, filled teeth. Prevalence of caries is reported in percentage (%) of participants for each group presenting the condition, if not otherwise specified through the use of specific parameters, expressed in mean ± SD (standard deviation) or only mean, depending on the study</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="t3-9">
<title>Factors associated with PD: duration and severity</title>
<p id="p-53">Three studies analysed the duration of the disease and its possible correlation with the oral cavity (see <xref ref-type="table" rid="t10">Tables 10</xref> and <xref ref-type="table" rid="t11">11</xref>). Two studies [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B29">29</xref>] reported an increase in difficulties in managing oral hygiene at home in relation to the increase in the duration of PD disease (see <xref ref-type="table" rid="t10">Table 10</xref>): patients with the disease for approximately 10 years (average duration) and limited abilities reported greater limitations in abilities compared to ones with the disease for approximately 7 years. van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>] declared an average duration of the disease of 9.1 ± 6.4 years and an increase in the number of teeth with conservative treatments and restorations.</p>
<table-wrap id="t10">
<label>Table 10</label>
<caption>
<p id="t10-p-1">Factors associated with PD: duration</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Variable</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">Barbe et al. [<xref ref-type="bibr" rid="B23">23</xref>], 2017</td>
<td>Self-reported difficulties in IOD associated with disease duration increase 7 years average duration of the disease (4.00–14.00): no limitations</td>
</tr>
<tr>
<td>10 years average duration of the disease (6.75–15.50): limited abilities</td>
</tr>
<tr>
<td rowspan="6">John et al. [<xref ref-type="bibr" rid="B29">29</xref>], 2021</td>
<td>DMFT &lt; 3 year (8.0 ± 65.1)</td>
</tr>
<tr>
<td>DMFT &gt; 3 year (7.33 ± 3.73)</td>
</tr>
<tr>
<td>OHI &lt; 3 year (2.98 ± 0.82)</td>
</tr>
<tr>
<td>OHI &gt; 3 year (3.2 ± 10.85)</td>
</tr>
<tr>
<td>MGI &lt; 3 year (1.47 ± 0.39)</td>
</tr>
<tr>
<td>MGI &gt; 3 year (1.57 ± 0.39)</td>
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>Increase in the number of teeth with conservative treatment associated with the duration of the disease (average duration 9.1 ± 6.4)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t10-fn-1">DMFT: decayed, missing, filled teeth; IOD: home oral hygiene; OHI: oral hygiene index; MGI: modified gingival index; PD: Parkinson’s disease. Specific parameters are expressed in mean ± SD (standard deviation), depending on the study</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="t11">
<label>Table 11</label>
<caption>
<p id="t11-p-1">Factors associated with PD: severity</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Article</bold>
</th>
<th>
<bold>Group</bold>
</th>
<th>
<bold>OHI</bold>
</th>
<th>
<bold>MGI</bold>
</th>
<th>
<bold>DMFT</bold>
</th>
<th>
<bold>BOP</bold>
</th>
<th>
<bold>PI</bold>
</th>
<th>
<bold>GI</bold>
</th>
<th>
<bold>Findings</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">John et al. [<xref ref-type="bibr" rid="B29">29</xref>], 2021</td>
<td>Mild severity</td>
<td>2.90 ± 0.81</td>
<td>1.44 ± 0.38</td>
<td>7.24 ± 4.06</td>
<td>2.2%</td>
<td>23.9%</td>
<td>-</td>
<td rowspan="2">
<list list-type="bullet">
<list-item>
<p>↑ BOP associated with rigidity, tremor, and depressive state</p>
</list-item>
<list-item>
<p>↑ Plaque, bleeding associated with rigidity and tremor tremors in the upper limbs</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td>Moderate severity</td>
<td>3.77 ± 0.52</td>
<td>1.82 ± 0.25</td>
<td>9.43 ± 5.68</td>
<td>2.0%</td>
<td>16.80%</td>
<td>-</td>
</tr>
<tr>
<td rowspan="4">Pradeep et al. [<xref ref-type="bibr" rid="B31">31</xref>], 2015</td>
<td>Control group</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>20.37 ± 6.40</td>
<td>1.35 ± 0.61</td>
<td>0.55 ± 0.48</td>
<td rowspan="4">-</td>
</tr>
<tr>
<td>I H&amp;Y stage</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>33.36 ± 6.68</td>
<td>2.17 ± 0.46</td>
<td>1.24 ± 0.47</td>
</tr>
<tr>
<td>II H&amp;Y stage</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>37.50 ± 4.38</td>
<td>2.31 ± 0.79</td>
<td>1.34 ± 0.36</td>
</tr>
<tr>
<td>III H&amp;Y stage</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>48.60 ± 5.78</td>
<td>2.77 ± 0.74</td>
<td>1.92 ± 0.46</td>
</tr>
<tr>
<td>van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>], 2018</td>
<td>
<bold>-</bold>
</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>
<list list-type="bullet">
<list-item>
<p>Need for daily support associated with illness severity</p>
</list-item>
<list-item>
<p>↑ Number of teeth with decay associated with disease severity</p>
</list-item>
<list-item>
<p>↑ Number of teeth with conservative treatment associated with disease severity</p>
</list-item>
</list>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t11-fn-1">DMFT: decayed, missing, filled teeth; OHI: oral hygiene index; MGI: modified gingival index; GI: gingivitis index; BoP: bleeding on probing; H&amp;Y: Hoehn &amp; Yahr stage; PI: plaque index; ↑: increase; PD: Parkinson’s disease. Specific parameters are expressed in % or mean ± SD (standard deviation), depending on the study</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p id="p-54">As reported in <xref ref-type="table" rid="t11">Table 11</xref>, the MDS-UPDRS-III scale was used in the studies analysed for the third part to evaluate, facial expressions, rigidity, tremors.</p>
<p id="p-55">John et al. [<xref ref-type="bibr" rid="B29">29</xref>] examined 32 patients suffering from PD, divided according to the Hoehn &amp; Yahr Scale: 25 patients placed in the first and second stages were considered as mild severity, while 7 patients in the third and fourth stages were registered as moderate severity. This study reported an increase of oral hygiene index (OHI) and MGI of the most severe patients. Analysing bleeding and the presence of plaque, Lyra et al. [<xref ref-type="bibr" rid="B30">30</xref>] documented an increase in these indices related to the presence of tremors, depressive state, and rigidity. Pradeep et al. [<xref ref-type="bibr" rid="B31">31</xref>] also reported an increase in clinical indices related to gingival inflammation associated with disease progression: examining 45 subjects suffering from PD and 46 healthy ones, and dividing the first group into five subgroups based on the Hoehn &amp; Yahr Scale, stages 1 and 2 represented mild severity, stage 3 moderate severity and stages 4 and 5 referred to severe disease. van Stiphout et al. [<xref ref-type="bibr" rid="B35">35</xref>] finally highlighted the increased need for home oral hygiene support in patients who have more severe disease, as well as a greater number of decayed teeth and with fillings when the severity of the disease increases. Therefore, in all the studies analysed, a significant worsening of the oral situation was noted when the disease was present for several years or in case of its aggravation.</p>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p id="p-56">Patient with PD generally present a lower oral health related quality of life (OHRQoL) compared to healthy individuals [<xref ref-type="bibr" rid="B25">25</xref>], due to xerostomia, dysphagia and sialorrhea, which alter the salivary clearance, negatively impact the microflora and cause halitosis [<xref ref-type="bibr" rid="B37">37</xref>]. Xerostomia is one of the most common oral manifestations in PD patients, found in 55% of cases [<xref ref-type="bibr" rid="B10">10</xref>], implying a decrease of saliva quantity and quality, linked to the disease itself or the drugs taken. Capacity of remineralising/buffering and antimicrobial power therefore determine carious lesions, periodontal pockets, as well as oral ulcers and problems with retention of prostheses [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. Furthermore, a reduced mobility and rigidity of the muscles, which promote the self-cleansing function, leads to infections and inflammation [<xref ref-type="bibr" rid="B34">34</xref>], with proliferation of a distinct microbiota in both saliva and subgingival plaque compared to healthy controls [<xref ref-type="bibr" rid="B26">26</xref>]. While dysphagia causes weight loss, social distancing (the patient prefers to isolate himself while eating), problems in taking medications, and acid reflux, with enamel erosion and dentin hypersensitivity [<xref ref-type="bibr" rid="B9">9</xref>], sialorrhea is connected to impaired swallowing and reduced lip closure.</p>
<p id="p-57">Concerning oral habits, outcomes examined in this review revealed for all studies an average frequency of brushing of at least twice a day for PD patients, while non homogenous data are reported for brushing technique used, with authors declaring a prevalent use of the electric toothbrush [<xref ref-type="bibr" rid="B36">36</xref>], vs. authors highlighting a prevalent use of the manual one [<xref ref-type="bibr" rid="B27">27</xref>]. Discrepancies between studies regarding brushing methods could be related to different samples considered, as PD patients were not always compared with healthy controls, and to different duration and severity of disease assessed. However, authors suggest that clinical recommendations should be driven by the necessity of simplify manoeuvres: electric device can represent a valid option in this sense, especially in case of severe phase of disease.</p>
<p id="p-58">Use of interdental devices in patients with PD seems to be lower compared to healthy patients in all articles examined, with a mean difference of approximately 15% between groups [<xref ref-type="bibr" rid="B27">27</xref>]. Due to evident difficulties at home beside they are aware of the need for good oral conditions [<xref ref-type="bibr" rid="B38">38</xref>], lack of adequate interdental cleaning easily leads to accumulation of biofilm, which was reported in greater quantities for PD patients by several studies [<xref ref-type="bibr" rid="B25">25</xref>–<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>]. Although frequency and modality of cleaning teeth can be superimposed with the comparison group, results did not show a sufficient plaque control, also for the presence of apathy, depression, and forgetfulness.</p>
<p id="p-59">In addition, gingival inflammation, registered through the presence of bleeding and gingivitis, is a consequence of deficient oral hygiene. Most studies reported a predominant presence of gingivitis in PD patients compared to healthy ones [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B29">29</xref>], with presence of bleeding in 57.9% of cases vs. 51.50% in the control group [<xref ref-type="bibr" rid="B26">26</xref>]. Incorrect oral hygiene, in terms of lack of quality (not frequency) of manoeuvres [<xref ref-type="bibr" rid="B11">11</xref>], usually promotes gingivitis, which, if prolonged, can evolve into periodontitis or worsen an already compromised periodontal status.</p>
<p id="p-60">Being chronic periodontitis an infectious disease linked to a variety of systemic disorders [<xref ref-type="bibr" rid="B39">39</xref>], several studies suggest a potential connection between chronic periodontitis and neurodegenerative diseases, such as PD [<xref ref-type="bibr" rid="B40">40</xref>]. Individuals with PD indeed present a bacterial composition different from healthy people; at the same time, patients with chronic periodontitis seem to have a higher risk of developing multi-organ systemic complications and PD, which can be reduced through improvement of oral health and regular periodontal treatment [<xref ref-type="bibr" rid="B39">39</xref>]. Understanding the mechanisms of biofilm alteration, constant inflammation, or even the bacterial products blood-circulation, would be advisable for periodontitis prevention: it was reported that microorganisms typical of <italic>red complex</italic>, such as <italic>P. gingivalis,</italic> are involved in neuroinflammation. Oral manifestations can be thus useful for an earlier diagnosis of systemic pathologies, or can represent the first steps of eventual chronic conditions, especially considering the slow and insidious progression of PD [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>]. As the microbial profile is associated with cognitive status [<xref ref-type="bibr" rid="B26">26</xref>], decrease in quantity of saliva, specific bacteria found in increased proportions (e.g., <italic>S. Mutans</italic>, <italic>Veillonella</italic>, <italic>Lactobacillaceae</italic>, <italic>T. Forsythia</italic>, <italic>P. Intermedia</italic>, <italic>Fusobacterium</italic>, <italic>Capnocytophaga</italic>, <italic>C. Rectus</italic>) and worsened periodontal conditions all suggest an increased risk for periodontal disease. Besides that, periodontal bacteria produce endotoxins, which increase the inflammatory impact and induce cells to generate and release pro-inflammatory cytokines, hypothesized to be associated with the damage or apoptosis of dopaminergic cells [<xref ref-type="bibr" rid="B43">43</xref>]: in this way, chronic inflammatory response due to periodontal disease seems to be one of the etiological causes of PD.</p>
<p id="p-61">All studies included in this review found a greater number of missing teeth, plaque accumulation, pronounced bone loss and increased periodontal pockets in PD patients. Specific investigations also demonstrated a greater number of pockets larger than 4 mm and of mobile elements in PD patients compared to control group [<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B44">44</xref>]. The number of elements present in the oral cavity does not seem to differ between PD patients and healthy patients: nevertheless, a greater number of root residues was found in the test group, probably because dental treatments are more difficult to perform in PD patients [<xref ref-type="bibr" rid="B35">35</xref>]. Neglection of pathological clinical signs leads to mobility and final loss of the dental elements [<xref ref-type="bibr" rid="B45">45</xref>], with consequent difficulty in chewing and swallowing and a further worsening of the quality of life [<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>]. In this terms, rehabilitation through the use of removable partial dentures can significantly decrease the scores of Oral Health Impact Profile-49 (OHIP-49) [<xref ref-type="bibr" rid="B32">32</xref>], a tool employed for measuring the effect of oral health on quality of life. PD patients, however, declared their prostheses as less comfortable than healthy patients [<xref ref-type="bibr" rid="B48">48</xref>], reporting a reduced motor control of the facial muscles. The presence of removable prostheses requires a strong effort to be kept in position or to be active during chewing and phonation even in healthy subjects: for PD patients orofacial muscles do no longer properly operate and react in self-control during oral functions, as the device is probably perceived by the patient as foreign compared with natural dentition. Plus, despite patients generally show greater satisfaction in terms of food intake and oral well-being, difficulty in cleaning prostheses, due to cognitive deterioration and motor disorders, can lead to the formation of a reservoir of pathogenic microorganisms [<xref ref-type="bibr" rid="B49">49</xref>]. In this regard, use of mouthwash is recommended to prevent opportunistic infections, and it was registered as similar in test and control group: however, it can be noticed that this supplement can generate discomfort in PD for dysphagia or fear of choking.</p>
<p id="p-62">Patients’ self-assessment of their oral hygiene was reported as moderate in the PD group and good in the control group: this is indicative of awareness, by PD patients, of being not sufficiently efficient and effective in oral hygiene manoeuvres. Despite the frequency of dental visits appears to be homogeneous among all authors, with regular visits at least twice per year, overall oral health in PD patients was finally found as deficient and inadequate [<xref ref-type="bibr" rid="B11">11</xref>]. Proper use of toothbrush and interdental aids require complex coordination and manual skills, with increasing difficulties as the disease advances. Even if appointments in dental practices could be frequent, cognitive decline and dementia prevent the patient from reporting symptoms/dental pain to professionals/caregivers and being truly compliant: that’s probably the reason why patients’ perception of oral health results worse than healthy people.</p>
<p id="p-63">A compromised status with multiple missing teeth can modify eating habits in time [<xref ref-type="bibr" rid="B11">11</xref>], as the patient present greater difficulty in chewing and swallowing, finally choosing softer and sweeter foods, which are rich of sugars, and limited self-cleansing of the oral cavity, with an increase in carious receptivity. Despite some authors [<xref ref-type="bibr" rid="B38">38</xref>] stated that factors predisposing oral diseases in PD patients include propensity for cariogenic foods, use of drugs reducing salivation, physical and motor problems, and cognitive change, only one paper [<xref ref-type="bibr" rid="B35">35</xref>] among five found a higher prevalence of caries in PD patients. Concomitant factors potentially leading to a greater predisposition to carious lesions [<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>] are poor oral hygiene, plaque accumulation, and change in oral flora with a prevalence of <italic>S. Mutans</italic> and <italic>Lactobacillaceae</italic>.</p>
<p id="p-64">Regarding relevant factors associated with the disease, its duration and severity both lead to general worsening of oral conditions. As the severity increases, functional capacity decreases in terms of motor difficulties and cognitive deficiencies, along with depression and dementia [<xref ref-type="bibr" rid="B12">12</xref>]. An evident link between severity/duration of PD and prevalence of untreated cavities and gingival inflammation clearly pointed out that compromised abilities in PD patients have an impact on the quality of self-care in a severe manner [<xref ref-type="bibr" rid="B11">11</xref>].</p>
<p id="p-65">Considering the exacerbation of clinical manifestations proceeding with the disease, the relevance of caregiver becomes extremely important in giving appropriate instructions, to determine an effective support in everyday difficulties. In practical terms, it is necessary for dental staff to focus on tailored oral hygiene protocols, paying attention to the real needs of patients and directly communicating with caregivers, to explain them how to improve oral hygiene with appropriate tools and precautions. Inadequate plaque control, with consequent gingival inflammation and bleeding, is certainly due to tremors, rigidity, dementia, which do not allow adequate manual skills. Furthermore, an unbalanced diet in favor of carbohydrates and sugars (simpler and more palatable), as well as an altered quantity and quality of saliva, can lead to greater carious receptivity. In the light of these considerations, all issues evidenced for PD patients in this review necessarily imply the need for specific assistance. Caregivers should be directly involved in patients oral care after a targeted training given by dentists and dental hygienists. Visual instructions should be performed with the caregiver and the patient present together in the dental office (if the disease allow mobility), or even at home. Appropriate methods of brushing should be verified in patient’s mouth to suggest the easiest and most effective way to eliminate plaque deposits. Manual capacity should be determined in terms of interdental cleaning, and suitable interdental devices should be chosen according to the grade of autonomy and compliance. Finally, informative flyer could be designed with the support with Dental Associations, to widely release knowledge about the orofacial management of PD patients.</p>
<p id="p-66">Finally, a limitation of the studies included in this review should be mentioned, as some authors [<xref ref-type="bibr" rid="B21">21</xref>–<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>] published on the topic in closed proximity, and probably the same populations were investigated in more than one study. Even if the results cannot be considered as representative of the countries they originated from, it must be underlined that multiple investigations by the same research group were conducted with different samples (PD patients only or PD patients in comparison with healthy group) and considering different factors influencing the disease (duration, stage severity). Despite the groups analyzed were almost homogeneous for age and type of study design (cross-sectional), differences were particularly evident regarding type of populations considered, indexes assessed for plaque and bleeding, oral parameters collected for examination of PD duration/severity. This heterogeneity does not allow a proper comparison between studies in terms of uniform analysis of multiple variables: taken for established the medical characterization of PD (with the known codified scales), this issue could be addressed with standardized methods, through the choice of universal clinical indexes for collection of parameters for an easy and practical evaluation of hard and soft tissues in the mouth.</p>
<p id="p-67">Considering these findings, the challenges faced by PD patients in home oral hygiene underscore the need for specific care. Areas of future research should encourage longitudinal studies to better understand the impact of oral health interventions on the progression of PD, not only through the action of private practice, but also with the support of families, caregivers and public structures involved in the assistance of PD patients.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>BoP</term>
<def>
<p>bleeding on probing</p>
</def>
</def-item>
<def-item>
<term>FMPI</term>
<def>
<p>full mouth plaque index</p>
</def>
</def-item>
<def-item>
<term>GI</term>
<def>
<p>gingivitis index</p>
</def>
</def-item>
<def-item>
<term>MDS-UPDRS-III</term>
<def>
<p>Movement Disorders Society-Unified Parkinson Disease Rating scale-part III</p>
</def>
</def-item>
<def-item>
<term>MGI</term>
<def>
<p>modified gingival index</p>
</def>
</def-item>
<def-item>
<term>OHI</term>
<def>
<p>oral hygiene index</p>
</def>
</def-item>
<def-item>
<term>OHIP-49</term>
<def>
<p>Oral Health Impact Profile-49</p>
</def>
</def-item>
<def-item>
<term>OHRQoL</term>
<def>
<p>oral health related quality of life</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p>Parkinson’s disease</p>
</def>
</def-item>
<def-item>
<term>PRISMA</term>
<def>
<p>Preferred Reporting Items for Systematic Reviews and Meta Analyses</p>
</def>
</def-item>
<def-item>
<term>RCTs</term>
<def>
<p>randomized clinical trials</p>
</def>
</def-item>
<def-item>
<term>SRQR</term>
<def>
<p>Standard for Reporting Qualitative Research</p>
</def>
</def-item>
</def-list>
</glossary>
<sec id="s5">
<title>Declarations</title>
<sec id="t-5-1">
<title>Author contributions</title>
<p>AP: Conceptualization, Investigation, Writing—original draft, Writing—review &amp; editing. AB: Conceptualization, Investigation, Writing—original draft. AS: Conceptualization, Investigation, Writing—original draft, Writing—review &amp; editing. MG: Writing—original draft, Writing—review &amp; editing. GB: Investigation, Writing—review &amp; editing. GC: Investigation, Writing—review &amp; editing. GL: Validation, Writing—review &amp; editing. MA: Validation, Writing-review &amp; editing, Supervision. All authors read and approved the submitted version.</p>
</sec>
<sec id="t-5-2" sec-type="COI-statement">
<title>Conflicts of interest</title>
<p>The authors declare that they have no conflicts of interest.</p>
</sec>
<sec id="t-5-3">
<title>Ethical approval</title>
<p>Not applicable.</p>
</sec>
<sec id="t-5-4">
<title>Consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec id="t-5-5">
<title>Consent to publication</title>
<p>Not applicable.</p>
</sec>
<sec id="t-5-6" sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The data presented in this study are available upon request from the corresponding author.</p>
</sec>
<sec id="t-5-7">
<title>Funding</title>
<p>Not applicable.</p>
</sec>
<sec id="t-5-8">
<title>Copyright</title>
<p>© The Author(s) 2024.</p>
</sec>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galvani-Townsend</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Is life expectancy higher in countries and territories with publicly funded health care? Global analysis of health care access and the social determinants of health</article-title>
<source>J Glob Health</source>
<year iso-8601-date="2022">2022</year>
<volume>12</volume>
<elocation-id>04091</elocation-id>
<pub-id pub-id-type="doi">10.7189/jogh.12.04091</pub-id>
<pub-id pub-id-type="pmid">36370409</pub-id>
<pub-id pub-id-type="pmcid">PMC9653205</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghezzi</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Ship</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Systemic diseases and their treatments in the elderly: impact on oral health</article-title>
<source>J Public Health Dent</source>
<year iso-8601-date="2000">2000</year>
<volume>60</volume>
<fpage>289</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1111/j.1752-7325.2000.tb03337.x</pub-id>
<pub-id pub-id-type="pmid">11243049</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Dorsey</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Achey</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Korn</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Arky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Biglan</surname>
<given-names>KM</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Do Video House Calls With a Specialist Help Get Care to People With Parkinson’s Disease? [Internet]</article-title>
<comment>Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018.</comment>
<pub-id pub-id-type="doi">10.25302/8.2018.AD.12114701</pub-id>
<pub-id pub-id-type="pmid">36996273</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tysnes</surname>
<given-names>OB</given-names>
</name>
<name>
<surname>Storstein</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Epidemiology of Parkinson’s disease</article-title>
<source>J Neural Transm (Vienna)</source>
<year iso-8601-date="2017">2017</year>
<volume>124</volume>
<fpage>901</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1007/s00702-017-1686-y</pub-id>
<pub-id pub-id-type="pmid">28150045</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Forsaa</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Dreetz</surname>
<given-names>Gjerstad M</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Epidemiology of Parkinson’s disease</article-title>
<source>J Neurol</source>
<year iso-8601-date="2008">2008</year>
<volume>255</volume>
<fpage>18</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-008-5004-3</pub-id>
<pub-id pub-id-type="pmid">18787879</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Einarsdóttir</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Gunnsteinsdóttir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hallsdóttir</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Sveinsson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jónsdóttir</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Olafsson</surname>
<given-names>VG</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Dental health of patients with Parkinson’s disease in Iceland</article-title>
<source>Spec Care Dentist</source>
<year iso-8601-date="2009">2009</year>
<volume>29</volume>
<fpage>123</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1111/j.1754-4505.2009.00075.x</pub-id>
<pub-id pub-id-type="pmid">19938251</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>García D</given-names>
</name>
<name>
<surname>Suárez</surname>
<given-names>Castro E</given-names>
</name>
<name>
<surname>Expósito</surname>
<given-names>I</given-names>
</name>
<name>
<surname>de Deus</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tuñas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Aneiros</surname>
<given-names>A</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Comorbid conditions associated with Parkinson’s disease: A longitudinal and comparative study with Alzheimer disease and control subjects</article-title>
<source>J Neurol Sci</source>
<year iso-8601-date="2017">2017</year>
<volume>373</volume>
<fpage>210</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2016.12.046</pub-id>
<pub-id pub-id-type="pmid">28131190</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dirks</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Paunovich</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Terezhalmy</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Chiodo</surname>
<given-names>LK</given-names>
</name>
</person-group>
<article-title>The patient with Parkinson’s disease</article-title>
<source>Quintessence Int</source>
<year iso-8601-date="2003">2003</year>
<volume>34</volume>
<fpage>379</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">12795358</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dougall</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fiske</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Access to special care dentistry, part 9. Special care dentistry services for older people</article-title>
<source>Br Dent J</source>
<year iso-8601-date="2008">2008</year>
<volume>205</volume>
<fpage>421</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bdj.2008.891</pub-id>
<pub-id pub-id-type="pmid">18953303</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedlander</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Mahler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Norman</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Ettinger</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Parkinson disease: systemic and orofacial manifestations, medical and dental management</article-title>
<source>J Am Dent Assoc</source>
<year iso-8601-date="2009">2009</year>
<volume>140</volume>
<fpage>658</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.14219/jada.archive.2009.0251</pub-id>
<pub-id pub-id-type="pmid">19491161</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auffret</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meuric</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Boyer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bonnaure-Mallet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vérin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Oral Health Disorders in Parkinson’s Disease: More than Meets the Eye</article-title>
<source>J Parkinsons Dis</source>
<year iso-8601-date="2021">2021</year>
<volume>11</volume>
<fpage>1507</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.3233/JPD-212605</pub-id>
<pub-id pub-id-type="pmid">34250950</pub-id>
<pub-id pub-id-type="pmcid">PMC8609694</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verhoeff</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Eikenboom</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Koutris</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Berendse</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>van Dijk</surname>
<given-names>KD</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Parkinson’s disease and oral health: A systematic review</article-title>
<source>Arch Oral Biol</source>
<year iso-8601-date="2023">2023</year>
<volume>151</volume>
<elocation-id>105712</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.archoralbio.2023.105712</pub-id>
<pub-id pub-id-type="pmid">37120970</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bollero</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cecchetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Miranda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barlattani</surname>
<given-names>A Jr</given-names>
</name>
<name>
<surname>Dolci</surname>
<given-names>A</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Oral health and implant therapy in Parkinson’s patients: review</article-title>
<source>Oral Implantol (Rome)</source>
<year iso-8601-date="2017">2017</year>
<volume>10</volume>
<fpage>105</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.11138/orl/2017.10.2.105</pub-id>
<pub-id pub-id-type="pmid">29876035</pub-id>
<pub-id pub-id-type="pmcid">PMC5965075</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moher</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liberati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tetzlaff</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>DG</given-names>
</name>
<collab>PRISMA Group</collab>
</person-group>
<article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement</article-title>
<source>Open Med</source>
<year iso-8601-date="2009">2009</year>
<volume>3</volume>
<fpage>e123</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">21603045</pub-id>
<pub-id pub-id-type="pmcid">PMC3090117</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Page</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Bossuyt</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Boutron</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Mulrow</surname>
<given-names>CD</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>
<source>BMJ</source>
<year iso-8601-date="2021">2021</year>
<volume>372</volume>
<elocation-id>n71</elocation-id>
<pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id>
<pub-id pub-id-type="pmid">33782057</pub-id>
<pub-id pub-id-type="pmcid">PMC8005924</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Brien</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Beckman</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Standards for reporting qualitative research: a synthesis of recommendations</article-title>
<source>Acad Med</source>
<year iso-8601-date="2014">2014</year>
<volume>89</volume>
<fpage>1245</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1097/ACM.0000000000000388</pub-id>
<pub-id pub-id-type="pmid">24979285</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sterne</surname>
<given-names>JAC</given-names>
</name>
<name>
<surname>Savović</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Elbers</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Blencowe</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Boutron</surname>
<given-names>I</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>RoB 2: a revised tool for assessing risk of bias in randomised trials</article-title>
<source>BMJ</source>
<year iso-8601-date="2019">2019</year>
<volume>366</volume>
<elocation-id>l4898</elocation-id>
<pub-id pub-id-type="doi">10.1136/bmj.l4898</pub-id>
<pub-id pub-id-type="pmid">31462531</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Downes</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)</article-title>
<source>BMJ Open</source>
<year iso-8601-date="2016">2016</year>
<volume>6</volume>
<elocation-id>e011458</elocation-id>
<pub-id pub-id-type="doi">10.1136/bmjopen-2016-011458</pub-id>
<pub-id pub-id-type="pmid">27932337</pub-id>
<pub-id pub-id-type="pmcid">PMC5168618</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goetz</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Tilley</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Shaftman</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Stebbins</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Fahn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martinez-Martin</surname>
<given-names>P</given-names>
</name>
<etal>et al.</etal>
<collab>Movement Disorder Society UPDRS Revision Task Force</collab>
</person-group>
<article-title>Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results</article-title>
<source>Mov Disord</source>
<year iso-8601-date="2008">2008</year>
<volume>23</volume>
<fpage>2129</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1002/mds.22340</pub-id>
<pub-id pub-id-type="pmid">19025984</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoehn</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Yahr</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Parkinsonism: onset, progression and mortality</article-title>
<source>Neurology</source>
<year iso-8601-date="1967">1967</year>
<volume>17</volume>
<fpage>427</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1212/wnl.17.5.427</pub-id>
<pub-id pub-id-type="pmid">6067254</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baram</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karlsborg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bakke</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Improvement of oral function and hygiene in Parkinson’s disease: A randomised controlled clinical trial</article-title>
<source>J Oral Rehabil</source>
<year iso-8601-date="2020">2020</year>
<volume>47</volume>
<fpage>370</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/joor.12924</pub-id>
<pub-id pub-id-type="pmid">31837276</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baram</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosing</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bakke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karlsborg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Øzhayat</surname>
<given-names>EB</given-names>
</name>
</person-group>
<article-title>Dental care utilization among persons with Parkinson’s disease in Denmark</article-title>
<source>Community Dent Oral Epidemiol</source>
<year iso-8601-date="2023">2023</year>
<volume>51</volume>
<fpage>527</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1111/cdoe.12809</pub-id>
<pub-id pub-id-type="pmid">36317764</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbe</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Bock</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Derman</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Felsch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Timmermann</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Noack</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson’s disease patients</article-title>
<source>Gerodontology</source>
<year iso-8601-date="2017">2017</year>
<volume>34</volume>
<fpage>135</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1111/ger.12237</pub-id>
<pub-id pub-id-type="pmid">27231151</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbe</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Deutscher</surname>
<given-names>DHC</given-names>
</name>
<name>
<surname>Derman</surname>
<given-names>SHM</given-names>
</name>
<name>
<surname>Hellmich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Noack</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Subjective and objective halitosis among patients with Parkinson’s disease</article-title>
<source>Gerodontology</source>
<year iso-8601-date="2017">2017</year>
<volume>34</volume>
<fpage>460</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/ger.12293</pub-id>
<pub-id pub-id-type="pmid">28857268</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbe</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Heinzler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Derman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hellmich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Timmermann</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Noack</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Hyposalivation and xerostomia among Parkinson’s disease patients and its impact on quality of life</article-title>
<source>Oral Dis</source>
<year iso-8601-date="2017">2017</year>
<volume>23</volume>
<fpage>464</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1111/odi.12622</pub-id>
<pub-id pub-id-type="pmid">27976483</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fleury</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zekeridou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lazarevic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gaïa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Giannopoulou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Genton</surname>
<given-names>L</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Oral Dysbiosis and Inflammation in Parkinson’s Disease</article-title>
<source>J Parkinsons Dis</source>
<year iso-8601-date="2021">2021</year>
<volume>11</volume>
<fpage>619</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.3233/JPD-202459</pub-id>
<pub-id pub-id-type="pmid">33646178</pub-id>
<pub-id pub-id-type="pmcid">PMC8150470</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García-De-La-Fuente</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Lafuente-Ibáñez-de-Mendoza</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lartitegui-Sebastián</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Marichalar-Mendia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Echebarria-Goikouria</surname>
<given-names>MÁ</given-names>
</name>
<name>
<surname>Aguirre-Urizar</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Facts and controversies regarding oral health in Parkinson’s disease: A case-control study in Spanish patients</article-title>
<source>Med Oral Patol Oral Cir Bucal</source>
<year iso-8601-date="2022">2022</year>
<volume>27</volume>
<fpage>e419</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.4317/medoral.25348</pub-id>
<pub-id pub-id-type="pmid">35368008</pub-id>
<pub-id pub-id-type="pmcid">PMC9445606</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García-de-la-Fuente</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Fernández-Jiménez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lafuente-Ibáñez-de-Mendoza</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lartitegui-Sebastián</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Marichalar-Mendia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Aguirre-Urizar</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Periodontal health in a population with Parkinson’s disease in Spain: a cross-sectional study</article-title>
<source>Med Oral Patol Oral Cir Bucal</source>
<year iso-8601-date="2023">2023</year>
<volume>28</volume>
<fpage>e32</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.4317/medoral.25540</pub-id>
<pub-id pub-id-type="pmid">36243992</pub-id>
<pub-id pub-id-type="pmcid">PMC9805330</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>John</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Vasanthy</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Madhavanpillai</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kuriakose</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Does parkinsonism affect periodontal health? A cross-sectional study in a tertiary hospital</article-title>
<source>J Indian Soc Periodontol</source>
<year iso-8601-date="2021">2021</year>
<volume>25</volume>
<fpage>538</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.4103/jisp.jisp_749_20</pub-id>
<pub-id pub-id-type="pmid">34898921</pub-id>
<pub-id pub-id-type="pmcid">PMC8603805</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyra</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Proença</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Domingos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Godinho</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>JJ</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Parkinson’s Disease, Periodontitis and Patient-Related Outcomes: A Cross-Sectional Study</article-title>
<source>Medicina (Kaunas)</source>
<year iso-8601-date="2020">2020</year>
<volume>56</volume>
<elocation-id>383</elocation-id>
<pub-id pub-id-type="doi">10.3390/medicina56080383</pub-id>
<pub-id pub-id-type="pmid">32751544</pub-id>
<pub-id pub-id-type="pmcid">PMC7466334</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pradeep</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Martande</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Raju</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Rustagi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Suke</surname>
<given-names>DK</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Clinical evaluation of the periodontal health condition and oral health awareness in Parkinson’s disease patients</article-title>
<source>Gerodontology</source>
<year iso-8601-date="2015">2015</year>
<volume>32</volume>
<fpage>100</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/ger.12055</pub-id>
<pub-id pub-id-type="pmid">23718321</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Oral Health in Elders with Parkinson’s Disease</article-title>
<source>Braz Dent J</source>
<year iso-8601-date="2016">2016</year>
<volume>27</volume>
<fpage>340</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1590/0103-6440201600881</pub-id>
<pub-id pub-id-type="pmid">27224571</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>Garcia RCM</given-names>
</name>
</person-group>
<article-title>Parkinson’s disease impairs masticatory function</article-title>
<source>Clin Oral Investig</source>
<year iso-8601-date="2017">2017</year>
<volume>21</volume>
<fpage>1149</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1007/s00784-016-1879-z</pub-id>
<pub-id pub-id-type="pmid">27291219</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozas</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Tribble</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Jeter</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>Oral Factors That Impact the Oral Microbiota in Parkinson’s Disease</article-title>
<source>Microorganisms</source>
<year iso-8601-date="2021">2021</year>
<volume>9</volume>
<elocation-id>1616</elocation-id>
<pub-id pub-id-type="doi">10.3390/microorganisms9081616</pub-id>
<pub-id pub-id-type="pmid">34442695</pub-id>
<pub-id pub-id-type="pmcid">PMC8402101</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Stiphout</surname>
<given-names>MAE</given-names>
</name>
<name>
<surname>Marinus</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Hilten</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Lobbezoo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>de Baat</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Oral Health of Parkinson’s Disease Patients: A Case-Control Study</article-title>
<source>Parkinsons Dis</source>
<year iso-8601-date="2018">2018</year>
<volume>2018</volume>
<elocation-id>9315285</elocation-id>
<pub-id pub-id-type="doi">10.1155/2018/9315285</pub-id>
<pub-id pub-id-type="pmid">29854385</pub-id>
<pub-id pub-id-type="pmcid">PMC5964533</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verhoeff</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lobbezoo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>van Leeuwen</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Schuller</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Koutris</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Oral health-related quality of life in patients with Parkinson’s disease</article-title>
<source>J Oral Rehabil</source>
<year iso-8601-date="2022">2022</year>
<volume>49</volume>
<fpage>398</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1111/joor.13304</pub-id>
<pub-id pub-id-type="pmid">35000220</pub-id>
<pub-id pub-id-type="pmcid">PMC9306816</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanaoka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kashihara</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson’s disease</article-title>
<source>J Clin Neurosci</source>
<year iso-8601-date="2009">2009</year>
<volume>16</volume>
<fpage>1279</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.jocn.2008.12.027</pub-id>
<pub-id pub-id-type="pmid">19570683</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batista</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Portela</surname>
<given-names>de Oliveira MT</given-names>
</name>
<name>
<surname>Magalhaes</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Bastos</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Oral Hygiene in Patients with Parkinson’s Disease</article-title>
<source>R I Med J (2013)</source>
<year iso-8601-date="2015">2015</year>
<volume>98</volume>
<fpage>35</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">26517254</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pardo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fiorini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zangani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Faccioni</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Signoriello</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>M</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Topical Agents in Biofilm Disaggregation: A Systematic Review and Meta-Analysis</article-title>
<source>J Clin Med</source>
<year iso-8601-date="2024">2024</year>
<volume>13</volume>
<elocation-id>2179</elocation-id>
<pub-id pub-id-type="doi">10.3390/jcm13082179</pub-id>
<pub-id pub-id-type="pmid">38673451</pub-id>
<pub-id pub-id-type="pmcid">PMC11050662</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Research progress on the relationship between chronic periodontitis and Parkinson’s disease</article-title>
<source>Zhejiang Da Xue Xue Bao Yi Xue Ban</source>
<year iso-8601-date="2022">2022</year>
<volume>51</volume>
<fpage>108</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.3724/zdxbyxb-2021-0111</pub-id>
<pub-id pub-id-type="pmid">35462470</pub-id>
<pub-id pub-id-type="pmcid">PMC9109767</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiorillo</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Oral Health: The First Step to Well-Being</article-title>
<source>Medicina (Kaunas)</source>
<year iso-8601-date="2019">2019</year>
<volume>55</volume>
<elocation-id>676</elocation-id>
<pub-id pub-id-type="doi">10.3390/medicina55100676</pub-id>
<pub-id pub-id-type="pmid">31591341</pub-id>
<pub-id pub-id-type="pmcid">PMC6843908</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiorillo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cervino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Laino</surname>
<given-names>L</given-names>
</name>
<name>
<surname>D’Amico</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mauceri</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tozum</surname>
<given-names>TF</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>
<italic>Porphyromonas gingivalis</italic>, Periodontal and Systemic Implications: A Systematic Review</article-title>
<source>Dent J (Basel)</source>
<year iso-8601-date="2019">2019</year>
<volume>7</volume>
<elocation-id>114</elocation-id>
<pub-id pub-id-type="doi">10.3390/dj7040114</pub-id>
<pub-id pub-id-type="pmid">31835888</pub-id>
<pub-id pub-id-type="pmcid">PMC6960968</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>XY</given-names>
</name>
</person-group>
<article-title>Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons</article-title>
<source>Neuropeptides</source>
<year iso-8601-date="2023">2023</year>
<volume>99</volume>
<elocation-id>102337</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.npep.2023.102337</pub-id>
<pub-id pub-id-type="pmid">37087783</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Müller</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Naharro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>GE</given-names>
</name>
</person-group>
<article-title>What are the prevalence and incidence of tooth loss in the adult and elderly population in Europe?</article-title>
<source>Clin Oral Implants Res</source>
<year iso-8601-date="2007">2007</year>
<volume>18</volume>
<fpage>2</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0501.2007.01459.x</pub-id>
<pub-id pub-id-type="pmid">17594365</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castagna</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lanaro</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Signoriello</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Periodontal Healing after Lower Third Molars Extraction: A Clinical Evaluation of Different Flap Designs</article-title>
<source>Healthcare (Basel)</source>
<year iso-8601-date="2022">2022</year>
<volume>10</volume>
<elocation-id>1587</elocation-id>
<pub-id pub-id-type="doi">10.3390/healthcare10081587</pub-id>
<pub-id pub-id-type="pmid">36011244</pub-id>
<pub-id pub-id-type="pmcid">PMC9408120</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albanese</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zangani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Manfrin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bertossi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Manzoni R</given-names>
</name>
<name>
<surname>Tomizioli</surname>
<given-names>N</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Influence of Surgical Technique on Post-Operative Complications in the Extraction of the Lower Third Molar: A Retrospective Study</article-title>
<source>Dent J (Basel)</source>
<year iso-8601-date="2023">2023</year>
<volume>11</volume>
<elocation-id>238</elocation-id>
<pub-id pub-id-type="doi">10.3390/dj11100238</pub-id>
<pub-id pub-id-type="pmid">37886923</pub-id>
<pub-id pub-id-type="pmcid">PMC10605236</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pardo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Signoriello</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Corrà</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Favero</surname>
<given-names>V</given-names>
</name>
<name>
<surname>De’Manzoni</surname>
<given-names>Casarola R</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Six-Month Soft Tissues Healing after Lower Third Molar Extraction: Comparison of Two Different Access Flaps</article-title>
<source>J Clin Med</source>
<year iso-8601-date="2023">2023</year>
<volume>12</volume>
<elocation-id>7017</elocation-id>
<pub-id pub-id-type="doi">10.3390/jcm12227017</pub-id>
<pub-id pub-id-type="pmid">38002631</pub-id>
<pub-id pub-id-type="pmcid">PMC10672238</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakayama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Washio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Oral health conditions in patients with Parkinson’s disease</article-title>
<source>J Epidemiol</source>
<year iso-8601-date="2004">2004</year>
<volume>14</volume>
<fpage>143</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.2188/jea.14.143</pub-id>
<pub-id pub-id-type="pmid">15478669</pub-id>
<pub-id pub-id-type="pmcid">PMC8787205</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Donnell</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nile</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Lappin</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Bradshaw</surname>
<given-names>D</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Dentures are a Reservoir for Respiratory Pathogens</article-title>
<source>J Prosthodont</source>
<year iso-8601-date="2016">2016</year>
<volume>25</volume>
<fpage>99</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1111/jopr.12342</pub-id>
<pub-id pub-id-type="pmid">26260391</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedullà</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Plotino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Scibilia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grande</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Santis D</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>A</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Cyclic fatigue comparison among endodontic instruments with similar cross section and different surface coating</article-title>
<source>Minerva Stomatol</source>
<year iso-8601-date="2019">2019</year>
<volume>68</volume>
<fpage>67</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.23736/S0026-4970.17.04009-2</pub-id>
<pub-id pub-id-type="pmid">27827527</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Agostino</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ferrara</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Valentini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Stoica</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Dolci</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Exploring Oral Microbiome in Healthy Infants and Children: A Systematic Review</article-title>
<source>Int J Environ Res Public Health</source>
<year iso-8601-date="2022">2022</year>
<volume>19</volume>
<elocation-id>11403</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijerph191811403</pub-id>
<pub-id pub-id-type="pmid">36141674</pub-id>
<pub-id pub-id-type="pmcid">PMC9517473</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>